Lisa Cencia Rohan, Ph.D holds appointments as Associate Professor in the Department of Pharmaceutical Sciences in the School of Pharmacy and the Department of Obstetrics, Gynecology, & Reproductive Sciences and the Clinical & Translational Science Institute in the School of Medicine at the University of Pittsburgh. She also is an Investigator at the Magee-Womens Research Institute. Dr. Rohan additionally serves as the Co-Director for the Comparative Assessment Core of the Central Laboratory for the Microbicide Trials Network (MTN), a U.S. National Institutes of Health-funded worldwide collaborative clinical trials network focused on preventing the sexual transmission of HIV.
Dr. Rohan obtained a B.S. in chemical engineering from West Virginia University and a Ph.D. in Pharmaceutics from the University of Pittsburgh. She completed her Postdoctoral Fellowship in the area of Mucosal Immunology. Prior to joining academics, Dr. Rohan spent several years in industry within Drug Development groups of Sterling Winthrop Pharmaceuticals and Kodak Pharmaceuticals, and was formerly the Director of Clinical Studies at Biodecision Laboratories. The basis of Dr. Rohan’s research lies in vaginal and cervical drug delivery as applied in the areas of infectious disease and gynecologic oncology. Her research has focused on design of drug delivery strategies and development of biologically relevant in vitro models for topical microbicides formulation assessment. Particular interests are in studying the role of chemical, physical, and biological properties of vaginal and cervical tissues and fluids in the development of vaginal and cervical products. Specifically, this knowledge is being utilized to develop more effective products for prophylactic use against Sexually Transmitted Diseases and HIV.